BioAtla, Inc. (BCAB)
1.71
+0.48
(+39.02%)
USD |
OTCM |
Oct 23, 16:00
BioAtla Price : 1.71 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.40 | 1.76 | 1.40 | 1.71 | 7323.00 |
| Oct 22, 2026 | 1.445 | 1.55 | 1.23 | 1.23 | 5232.00 |
| Oct 21, 2026 | 1.34 | 1.50 | 1.34 | 1.356 | 3617.00 |
| Oct 20, 2026 | 1.36 | 1.525 | 1.30 | 1.33 | 5337.00 |
| Oct 19, 2026 | 1.22 | 1.31 | 1.22 | 1.31 | 2183.00 |
| Oct 16, 2026 | 1.36 | 1.36 | 1.22 | 1.36 | 1412.00 |
| Oct 15, 2026 | 1.30 | 1.30 | 1.29 | 1.30 | 3283.00 |
| Oct 14, 2026 | 1.29 | 1.30 | 1.25 | 1.30 | 3911.00 |
| Oct 13, 2026 | 1.28 | 1.28 | 1.27 | 1.28 | 11852.00 |
| Oct 12, 2026 | 1.39 | 1.39 | 1.249 | 1.25 | 9317.00 |
| Oct 09, 2026 | 1.55 | 1.57 | 1.34 | 1.50 | 2906.00 |
| Oct 08, 2026 | 1.65 | 1.65 | 1.50 | 1.55 | 5829.00 |
| Oct 07, 2026 | 1.23 | 1.59 | 1.23 | 1.59 | 10118.00 |
| Oct 06, 2026 | 1.31 | 1.46 | 1.22 | 1.35 | 11086.00 |
| Oct 05, 2026 | 1.31 | 1.32 | 1.23 | 1.32 | 1390.00 |
| Oct 02, 2026 | 1.23 | 1.65 | 1.23 | 1.31 | 3477.00 |
| Oct 01, 2026 | 1.45 | 1.45 | 1.26 | 1.26 | 3495.00 |
| Sep 30, 2026 | 1.45 | 1.45 | 1.262 | 1.30 | 16735.00 |
| Sep 29, 2026 | 1.55 | 1.65 | 1.36 | 1.36 | 6530.00 |
| Sep 28, 2026 | 1.48 | 1.88 | 1.384 | 1.52 | 11050.00 |
| Sep 25, 2026 | 1.31 | 1.48 | 1.17 | 1.48 | 10813.00 |
| Sep 24, 2026 | 1.41 | 1.58 | 1.41 | 1.52 | 1979.00 |
| Sep 23, 2026 | 1.75 | 1.78 | 1.31 | 1.59 | 35105.00 |
| Sep 22, 2026 | 1.74 | 1.77 | 1.44 | 1.77 | 12652.00 |
| Sep 21, 2026 | 1.71 | 2.03 | 1.41 | 1.92 | 21983.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.02 |
| Oncolytics Biotech, Inc. | 0.5023 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 17.73 |
| Anixa Biosciences, Inc. | 2.99 |
Price Related Metrics
| PS Ratio | 0.2783 |
| Earnings Yield | -1.49K% |
| Market Cap | 2.844M |